139 related articles for article (PubMed ID: 27342518)
1. [Correlation between Plasma microRNA Expression and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
Hu B; Fu W; Huang SY; Gao XT; Li DH; Yan XQ; Zhang YP; Liu Q; Liu L; Liang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):827-32. PubMed ID: 27342518
[TBL] [Abstract][Full Text] [Related]
2. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
4. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
[TBL] [Abstract][Full Text] [Related]
7. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
[TBL] [Abstract][Full Text] [Related]
9. [Plasma MiR-181b and MiR-194 As Biomarkers for Acute Graft- Versus-Host Disease and Significance of Their Changes].
Chen Y; Deng HL; Kang DL; Wang Y; Hong XL; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):957-962. PubMed ID: 34105500
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA155 is increased in patients with acute graft-versus-host disease.
Xie LN; Zhou F; Liu XM; Fang Y; Yu Z; Song NX; Kong FS
Clin Transplant; 2014 Mar; 28(3):314-23. PubMed ID: 24494749
[TBL] [Abstract][Full Text] [Related]
11. Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.
Atarod S; Norden J; Bibby LA; Janin A; Ratajczak P; Lendrem C; Pearce KF; Wang XN; O'Reilly S; Van Laar JM; Collin M; Dickinson AM; Crossland RE
Front Immunol; 2018; 9():1485. PubMed ID: 30042760
[TBL] [Abstract][Full Text] [Related]
12. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study.
Motaei J; Kerachian MA; Mousavi SA; Alimoghadam K; Ghavamzadeh A; Manoochehrabadi S; Ahmadvand M; Yaghmaie M
Ann Hematol; 2021 Oct; 100(10):2621-2631. PubMed ID: 34247256
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
[TBL] [Abstract][Full Text] [Related]
16. [SIRT1 deficiency in CD4+T cells induces acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Zhang Y; Yang J; Zhang G; Peng J; Chen X; Chen F; Xu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):697-703. PubMed ID: 30124203
[TBL] [Abstract][Full Text] [Related]
17. [Increment of chemokine CXCL9/Mig in plasma correlated with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Ji LH; Ren HY; Shi YJ; Cen XN; Qiu ZX; Ou JP; Xu WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1200-3. PubMed ID: 17204194
[TBL] [Abstract][Full Text] [Related]
18. [The Relationship between Plasma sST2/Reg3α Levels and Acute Graft-Versus-Host Disease in Children After Allogeneic Hematopoietic Stem Cell Transplantation].
Zhang AP; Xiong H; Wang Z; Yang L; Qi SS; Nie YM; Chen Z; Teng JX; Wu S; Li JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1334-1339. PubMed ID: 34362526
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
